| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $2.4M | -17.3% | +72.5% |
| Cost of Revenue | $1.1M | -16.6% | +79.5% |
| Gross Profit | $1.3M | -17.9% | +66.9% |
| R&D Expense | $1.5M | +5.6% | -2.8% |
| SG&A Expense | $1.9M | +1.8% | -1.1% |
| Operating Income | -$2.1M | -23.1% | +21.6% |
| Pre-tax Income | -$2.1M | -45.1% | +8.1% |
| Net Income | -$2.1M | -45.1% | +8.1% |
| EPS (Basic) | -$0.25 | -733.3% | -257.1% |
| EPS (Diluted) | -$0.25 | -733.3% | -257.1% |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $2.8M | -21.3% | +112.4% |
| Accounts Receivable | $2.4M | -8.8% | +661.2% |
| Inventory | $1.9M | +12.0% | +1.7% |
| Current Assets | $7.4M | -8.2% | +97.2% |
| Total Assets | $7.9M | -8.3% | +76.5% |
| Current Liabilities | $1.7M | +34.2% |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$4.4M | -42.6% | — |
| Capital Expenditures | $79K | +94.5% | — |
| Investing Cash Flow | -$79K | -94.5% | — |
| Financing Cash Flow | $757K | +412.4% | — |
| Free Cash Flow | -$4.5M | -43.3% | — |
| -4.2% |
| Total Liabilities | $2.5M | +14.5% | -25.2% |
| Stockholders' Equity | $5.4M | -16.1% | +377.3% |